Market Capitalization of Concord Biotech (CONCORDBIO)
As of Aug. 25, 2026, Concord Biotech (CONCORDBIO) market capitalisation is ₹16379.76 Cr ($1.82B), with 10.58 Cr shares outstanding at a current price of ₹1548.00 on NSE, ranking 430 out of 5366 companies by market cap in our screener. Concord Biotech operates in the Healthcare sector and is classified as a Mid Cap stock. Browse Concord Biotech annual reports for revenue, profit, balance sheet and cash flow data.
Market Cap History of Concord Biotech (Last 10 Years)
CONCORDBIO market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Concord Biotech share price screener.
End of Year Market Cap History — Concord Biotech
CONCORDBIO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Examine CONCORDBIO Q4 results for recent quarterly revenue, profit and EPS trends.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹16379.76 Cr
$1.82B USD
|
₹1548.00 | NSE | +15.04% |
| 2025 |
₹14238.12 Cr
$1.58B USD
|
₹1345.60 | NSE | -39.13% |
| 2024 |
₹23392.48 Cr
$2.60B USD
|
₹2210.75 | NSE | +50.21% |
| 2023 |
₹15573.47 Cr
$1.73B USD
|
₹1471.80 | NSE | - |